N-acetyl cysteine for treatment of recurrent unexplained pregnancy loss

Reproductive BioMedicine Online

Volumn 17, Issue 5, 2008, Pages 722-726

  Amin, Ahmed F ^a   Shaaban, Omar M ^a   Bediawy, Mohamed A ^a  

^a Assiut University Faculty of Medicine   (Egypt)

Author keywords

Antioxidant; Folic acid; N acetyl cysteine; Pregnancy; Recurrent miscarriage

Indexed keywords

ACETYLCYSTEINE; FOLIC ACID;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EGYPT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; OXIDATIVE STRESS; PREGNANCY RATE; RECURRENT ABORTION; RISK FACTOR; SPONTANEOUS ABORTION; THERAPY EFFECT; UNSPECIFIED SIDE EFFECT;

EID: 56749144149     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60322-7     Document Type: Article

References (25)

1. Agarwal A, Gupta S, Sharma R 2005 Oxidative stress and its implications in female infertility - a clinician's perspective. Reproductive BioMedicine Online 11, 641-650.
2. Aluigi MG, De Flora S, D'Agostini F et al. 2000 Antiapoptotic and antigenotoxic effects of N-acetylcysteine in human cells of endothelial origin. Anticancer Research 20, 3183-3187.
3. American College of Obstetricians and Gynecologists 2000 Management of recurrent pregnancy loss. Practice Bulletin Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). International Journal of Gynaecology and Obstetrics 78, 179-190.
4. Buhimschi IA, Buhimschi CS, Weiner CP 2003 Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation. American Journal of Obstetrics and Gynaecology 188, 203-208.
5. Choi HK, Choi BC, Lee SH et al. 2003 Expression of angiogenesis-and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients. Molecular Reproduction and Development 66, 24-31.
6. Cotgreave IA 1997 N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Advances in Pharmacology 38, 205-227.
7. Halliwell B 1996 Antioxidants in human health and disease. Annual Review of Nutrition 16, 33-50.
8. Hempstock J, Jauniaux E, Greenwold N, Burton GJ 2003 The contribution of placental oxidative stress to early pregnancy failure. Human Pathology 34, 1265-1275.
9. Jauniaux E, Burton GJ 2005 Pathophysiology of histological changes in early pregnancy loss. Placenta 26, 114-123.
10. Jauniaux E, Gulbis B, Burton GJ 2003a Physiological implications of the materno-fetal oxygen gradient in human early pregnancy. Reproductive Biomedicine Online 7, 250-253.
11. Jauniaux E, Hempstock J, Greenwold N, Burton GJ 2003b Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. American Journal of Pathology 162,115-125.
12. Jauniaux E, Watson AL, Hempstock J et al. 2000 Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. American Journal of Pathology 157, 2111-2122.
13. Jenkins C, Wilson R, Roberts J et al. 2000 Antioxidants: their role in pregnancy and miscarriage. Antioxidants and Redox Signaling 2, 623-628.
14. Kelly GS 1998 Clinical applications of N-acetylcysteine. Alternative Medicine Review 3, 114-127.
15. Lappas M, Permezel M, Rice GE 2003 N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. Journal of Clinical Endocrinology and Metabolism 88, 1723-1729.
16. Myatt L, Cui X 2004 Oxidative stress in the placenta. histochemistry and cell biology. Histochemistry and Cell Biology 122, 369-382.
17. Ohyama K, Yuan B, Bessho T, Yamakawa T 2001 Progressive apoptosis in chorion laeve trophoblast cells of human fetal membrane tissues during in-vitro incubation is suppressed by antioxidative reagents. European Journal of Biochemistry 268, 6182-6189.
18. Ornaghi F, Ferrini S, Prati M, Giavini E 1993 The protective effects of N-acetyl-L-cysteine against methyl mercury embryotoxicity in mice. Fundamental and Applied Toxicology 20, 437-445.
19. Poston L, Raijmakers MT 2004 Trophoblast oxidative stress, antioxidants and pregnancy outcome - a review. Placenta 25 (Suppl. A), S72-S78.
20. Quadrilatero J, Hoffman-Goetz L 2004 N-Acetyl-L-cysteine prevents exercise-induced intestinal lymphocyte apoptosis by maintaining intracellular glutathione levels and reducing mitochondrial membrane depolarization. Biochemical and Biophysical Research Communications 319, 894-901.
21. Riggs BS, Bronstein AC, Kulig K, Archer PG. Rumack BH 1989 Acute acetaminophen overdose during pregnancy. Obstetrics and Gynecology 74, 247-253.
22. Rizk AY, Bedaiwy MA, Al-Inany HG 2005 N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertility and Sterility 83, 367-370.
23. Roes EM, Raijmakers MT, Boo TM et al. 2006 Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia. European Journal of Obstetrics, Gynecology and Reproductive Biology 127, 61-67.
24. Wentzel P, Thunberg L, Eriksson UJ 1997 Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia 40, 7-14.
25. Xu DX, Chen YH, Wang H et al. 2005 Effect of N-acetylcysteine on lipopolysaccharide-induced intra-uterine fetal death and intra-uterine growth retardation in mice. Toxicological Sciences 88, 525-533.